In NSCLC cells, elevated Gal-9 expression is linked to prolonged survival, while high levels of Gal-9 in tumor-infiltrating lymphocytes (TILs) are associated with early tumor recurrence. Here, LGALS9 is linked to non-small cell lung carcinoma.